Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 2
1987 3
1989 2
1996 3
1997 1
1999 3
2000 4
2001 2
2002 1
2003 2
2006 1
2007 1
2011 1
2014 2
2015 4
2016 6
2017 5
2018 7
2019 6
2020 5
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells.
Sugata K, Matsunaga Y, Yamashita Y, Nakatsugawa M, Guo T, Halabelian L, Ohashi Y, Saso K, Rahman MA, Anczurowski M, Wang CH, Murata K, Saijo H, Kagoya Y, Ly D, Burt BD, Butler MO, Mak TW, Hirano N. Sugata K, et al. Among authors: saso k. Nat Biotechnol. 2021 Aug;39(8):958-967. doi: 10.1038/s41587-021-00836-4. Epub 2021 Mar 1. Nat Biotechnol. 2021. PMID: 33649568
Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer.
Nakata K, Komori T, Saso K, Ota H, Kagawa Y, Morita S, Noura S, Hayashi N, Uemura M, Matsuda C, Satoh T, Mizushima T, Murata K, Doki Y, Eguchi H; Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO). Nakata K, et al. Among authors: saso k. Int J Colorectal Dis. 2021 Dec;36(12):2621-2627. doi: 10.1007/s00384-021-04002-9. Epub 2021 Aug 3. Int J Colorectal Dis. 2021. PMID: 34345969 Clinical Trial.
60 results